Evidence map›Paper›PMID 40821302›Full record

ArticleCureus2025

Neurofibromatosis Type 2: A Rare Case of Multiple Intracranial Schwannomas, Meningiomas, and Ependymomas (MISME) Syndrome and Literature Review.

Lagtarna Hamza, Naji Yahya, Hrouch Wafa, Chouaf Loubna, Laadami Sara, Adali Nawal

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lagtarna HamzaNeurology Department, Agadir University Hospital, Agadir, MAR.
Naji YahyaNeurology Department, Agadir University Hospital, Agadir, MAR.
Hrouch WafaNeurology Department, Agadir University Hospital, Agadir, MAR.
Chouaf LoubnaNeurology Department, Agadir University Hospital, Agadir, MAR.
Laadami SaraNeurology Department, Agadir University Hospital, Agadir, MAR.
Adali NawalNeurology Department, Agadir University Hospital, Agadir, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 2 (NF2) is a rare genetic disorder affecting the nervous system, primarily characterized by benign tumor formation, including bilateral vestibular schwannomas, meningiomas, and ependymomas. These tumors are collectively known as MISME (multiple intracranial schwannomas, meningiomas, and ependymomas) syndrome. We report a case of a 35-year-old woman with no notable medical or family history, who presented with progressive hearing loss and right upper limb weakness. Magnetic resonance imaging revealed multiple central nervous system tumors, confirming the diagnosis of NF2. The patient was referred to the neurosurgery department for further management; however, no follow-up information was received, and it was suspected that the patient may have sought care elsewhere. This case underscores the diverse clinical manifestations of NF2 and emphasizes the critical role of neuroimaging in the early diagnosis of the condition. A multidisciplinary approach is essential for optimal care, and future advances in targeted therapy may significantly improve patient outcomes. Clinicians should remain vigilant for the diverse presentations of NF2, as early detection and comprehensive management can positively influence the disease progression and quality of life.

Indexed as

astrocytomameningiomasmisme syndromeneurofibromatosis type 2nf2 genevestibular schwannomas

Identifiers

PMID40821302
PMCPMC12357116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.